Last reviewed · How we verify

NCT04403958: PROOF II

The Use of Proximal Carpal Row Versus Iliac Crest as Bone Graft in Total Wrist Fusion

Status unknown NA Last updated 30 March 2021
What this trial tests

NA trial testing PRC in Wrist Arthritis in 84 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
31 December 2023
31 December 2024

Quick facts

Lead sponsorTöölö Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment84
Start date1 September 2021
Primary completion31 December 2023
Estimated completion31 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Töölö Hospital

Who can join

Adults 18 to 75, any sex, with Wrist Arthritis or Fusion; Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study purpose is to compare the outcome after total wrist arthrodesis (TWA) with proximal carpal row (Proximal Row Carpectomy = PRC) as bone graft versus iliac crest cancellous bone graft. Patients with radiologically and clinically confirmed advanced osteoarthritis are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either total wrist arthrodesis with PRC or TWA with iliac crest bone grafting. Baseline data is collected preoperatively and is a follow-up visits at every 6 weeks after the surgery is arranged until the wrist is fused. The primary end-point is 6 months and the primary outcome is fusion rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wrist Arthritis

Currently open trials in the same condition.

Other Töölö Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04403958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing